Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

N-[4-(3-amino-1H-indazol-4-yl)phenyl]-Nī-(2-fluoro-5-methylphenyl) urea

EU orphan designation number: EU/3/07/517   
Active ingredient: N-[4-(3-amino-1H-indazol-4-yl)phenyl]-Nī-(2-fluoro-5-methylphenyl) urea
Indication: Treatment of hepatocellular carcinoma
Sponsor: AbbVie Ltd
Maidenhead, SL6 4XE, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/12/2007 Centralised Orphan - Designation EMEA/OD/090/07 (2007)6812 of 20/12/2007
08/02/2013 Centralised Orphan - Transfer of orphan designation EMA/OD/090/07/T/01 (2013)732 of 06/02/2013